Centene, the massive American third-party administrator, is increasing its 50% stake in Spanish health management group Ribera Salud to 90%. The deal, which is going through regulatory approval, values Ribera at €125-140m and could be a signal of more acquisitions outside the US as the health reform which helped it grow looks increasingly under attack by President Trump.
Search over 7,000 articles
